PURDUE PHARMA (CANADA) RESPONSE TO FEDERAL MINISTER OF HEALTH

June 29, 2018

In response to a request from the Federal Minister of Health, in a letter dated June 19, 2018, to support Canada’s response to the opioids crisis, Purdue Pharma (Canada) responded to the Minister as follows:

2018-06-27 CEO letter to Minister Petitpas Taylor

click here to view letter